Responses
Sjögren syndrome
Short report
Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Compose a Response to This Article
Other responses
No responses have been published for this article.